Abstract
A preliminary report on the symptomatic effect of clonidine in severe hyperemesis gravidarum (HG). Observational. Hospital based: Ospedale Sant'Anna, Torino, Italy. Twelve pregnant women, 8-16 weeks, affected by severe, refractory HG. Assessment by two clinical score indexes: Pregnancy Unique Quantification of Emesis (PUQE) score and a Visual Analogue Scale (VAS) 5-item questionnaire, filled out daily, to detect subjective improvement or worsening of symptoms. PUQE score and VAS score before and after transdermal clonidine treatment. We found substantial improvement of symptoms and severity score indexes after four and 14 days. The comparison of pretreatment and post-treatment scores shows a significant statistical difference P < 0.0001. Transdermal clonidine may be considered as a treatment for resistant severe HG.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
